Pooled analysis from both SURMOUNT-1 and SURPASS-2 demonstrates reduced MACEs and cardiovascular death, by 48% and 49%, respectively [104]
Currently Available Treatment Tirzepatide Tirzepatide is FDA-approved and available as Mounjaro (T2D) and Zepbound (obesity)
Studies suggest BPC-157 may promote peripheral nerve regeneration after crush injuries, with documented improvements in nerve fiber density and functional recovery
Peptide therapy addresses the underlying tissue damage, promoting mucosal healing, reducing inflammation at the source, and supporting the gut's natural regenerative capacity
BPC-157 Oral 100 500mcg Recovery BPC-157 oral tablets
In addition to exposure to an EE in the acute phase after the stroke, which leads to a neuroprotective effect and improve functional outcome, Tang et al